DAXOR CORP (DXR) Stock Fundamental Analysis

NASDAQ:DXR • US2394671034

11.86 USD
-0.09 (-0.75%)
Last: Feb 27, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Taking everything into account, DXR scores 3 out of 10 in our fundamental rating. DXR was compared to 185 industry peers in the Health Care Equipment & Supplies industry. The financial health of DXR is average, but there are quite some concerns on its profitability. DXR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year DXR was profitable.
  • DXR had a positive operating cash flow in the past year.
  • Of the past 5 years DXR 4 years were profitable.
  • DXR had negative operating cash flow in 4 of the past 5 years.
DXR Yearly Net Income VS EBIT VS OCF VS FCFDXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.01%, DXR belongs to the top of the industry, outperforming 81.62% of the companies in the same industry.
  • DXR has a better Return On Equity (5.05%) than 77.30% of its industry peers.
Industry RankSector Rank
ROA 5.01%
ROE 5.05%
ROIC N/A
ROA(3y)6.45%
ROA(5y)5.61%
ROE(3y)6.73%
ROE(5y)6.34%
ROIC(3y)N/A
ROIC(5y)N/A
DXR Yearly ROA, ROE, ROICDXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • DXR has a Profit Margin of 2707.08%. This is amongst the best in the industry. DXR outperforms 100.00% of its industry peers.
  • In the last couple of years the Profit Margin of DXR has declined.
  • DXR does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 2707.08%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-35.84%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DXR Yearly Profit, Operating, Gross MarginsDXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • DXR has more shares outstanding than it did 1 year ago.
  • DXR has more shares outstanding than it did 5 years ago.
  • DXR has a better debt/assets ratio than last year.
DXR Yearly Shares OutstandingDXR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
DXR Yearly Total Debt VS Total AssetsDXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • DXR has an Altman-Z score of 154.30. This indicates that DXR is financially healthy and has little risk of bankruptcy at the moment.
  • DXR's Altman-Z score of 154.30 is amongst the best of the industry. DXR outperforms 100.00% of its industry peers.
  • The Debt to FCF ratio of DXR is 0.19, which is an excellent value as it means it would take DXR, only 0.19 years of fcf income to pay off all of its debts.
  • DXR's Debt to FCF ratio of 0.19 is amongst the best of the industry. DXR outperforms 92.43% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that DXR is not too dependend on debt financing.
  • DXR has a Debt to Equity ratio of 0.01. This is in the better half of the industry: DXR outperforms 72.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.19
Altman-Z 154.3
ROIC/WACCN/A
WACCN/A
DXR Yearly LT Debt VS Equity VS FCFDXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • DXR has a Current Ratio of 0.04. This is a bad value and indicates that DXR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DXR has a Current ratio of 0.04. This is amonst the worse of the industry: DXR underperforms 96.76% of its industry peers.
  • DXR has a Quick Ratio of 0.04. This is a bad value and indicates that DXR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of DXR (0.04) is worse than 96.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
DXR Yearly Current Assets VS Current LiabilitesDXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 22.53% over the past year.
  • Measured over the past years, DXR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -54.84% on average per year.
  • The Revenue for DXR has decreased by -56.97% in the past year. This is quite bad
  • Measured over the past years, DXR shows a very negative growth in Revenue. The Revenue has been decreasing by -20.63% on average per year.
EPS 1Y (TTM)22.53%
EPS 3Y-54.84%
EPS 5YN/A
EPS Q2Q%77.93%
Revenue 1Y (TTM)-56.97%
Revenue growth 3Y-24.67%
Revenue growth 5Y-20.63%
Sales Q2Q%-74.37%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue is expected to grow by 902.04% on average over the next years. This is a very strong growth
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5806.43%
Revenue Next 2Y902.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DXR Yearly Revenue VS EstimatesDXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
DXR Yearly EPS VS EstimatesDXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.02 0.04 0.06 0.08

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 28.93, the valuation of DXR can be described as expensive.
  • DXR's Price/Earnings ratio is a bit cheaper when compared to the industry. DXR is cheaper than 74.59% of the companies in the same industry.
  • DXR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.93
Fwd PE N/A
DXR Price Earnings VS Forward Price EarningsDXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 73.51% of the companies in the same industry are more expensive than DXR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 49.86
EV/EBITDA N/A
DXR Per share dataDXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • DXR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DAXOR CORP

NASDAQ:DXR (2/27/2026, 8:00:02 PM)

11.86

-0.09 (-0.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)03-04
Inst Owners1.73%
Inst Owner Change14.28%
Ins Owners5.89%
Ins Owner Change0.41%
Market Cap69.14M
Revenue(TTM)66.40K
Net Income(TTM)1.80M
Analysts80
Price Target23.8 (100.67%)
Short Float %0.23%
Short Ratio1.29
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 28.93
Fwd PE N/A
P/S 1041.32
P/FCF 49.86
P/OCF 49.86
P/B 1.94
P/tB 1.94
EV/EBITDA N/A
EPS(TTM)0.41
EY3.46%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.24
FCFY2.01%
OCF(TTM)0.24
OCFY2.01%
SpS0.01
BVpS6.11
TBVpS6.11
PEG (NY)N/A
PEG (5Y)N/A
Graham Number7.51
Profitability
Industry RankSector Rank
ROA 5.01%
ROE 5.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2707.08%
GM N/A
FCFM 2088.4%
ROA(3y)6.45%
ROA(5y)5.61%
ROE(3y)6.73%
ROE(5y)6.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-35.84%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.19
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 77.15%
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z 154.3
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.53%
EPS 3Y-54.84%
EPS 5YN/A
EPS Q2Q%77.93%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-56.97%
Revenue growth 3Y-24.67%
Revenue growth 5Y-20.63%
Sales Q2Q%-74.37%
Revenue Next Year5806.43%
Revenue Next 2Y902.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-83.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y144.02%
FCF growth 3YN/A
FCF growth 5Y-61.68%
OCF growth 1Y144.02%
OCF growth 3YN/A
OCF growth 5Y-61.68%

DAXOR CORP / DXR FAQ

Can you provide the ChartMill fundamental rating for DAXOR CORP?

ChartMill assigns a fundamental rating of 3 / 10 to DXR.


Can you provide the valuation status for DAXOR CORP?

ChartMill assigns a valuation rating of 2 / 10 to DAXOR CORP (DXR). This can be considered as Overvalued.


Can you provide the profitability details for DAXOR CORP?

DAXOR CORP (DXR) has a profitability rating of 3 / 10.


How financially healthy is DAXOR CORP?

The financial health rating of DAXOR CORP (DXR) is 5 / 10.


Can you provide the dividend sustainability for DXR stock?

The dividend rating of DAXOR CORP (DXR) is 0 / 10 and the dividend payout ratio is 0%.